Cyclerion Therapeutics, Inc.

NasdaqCM:CYCN Stock Report

Mkt Cap: US$31.1m

Cyclerion Therapeutics Financial Health

How is Cyclerion Therapeutics's financial position?

Financial Health Score

4/6

Financial Health Score 4/6

  • Short Term Liabilities

  • Long Term Liabilities

  • Debt Level

  • Reducing Debt

  • Stable Cash Runway

  • Forecast Cash Runway

Financial Position Analysis

Short Term Liabilities: CYCN's short term assets ($21.7M) exceed its short term liabilities ($8.5M).

Long Term Liabilities: CYCN has no long term liabilities.


Debt to Equity History and Analysis

Debt Level: CYCN is debt free.

Reducing Debt: CYCN had no debt 5 years ago.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss making in the past we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: CYCN has less than a year of cash runway based on its current free cash flow.

Forecast Cash Runway: CYCN has less than a year of cash runway if free cash flow continues to grow at historical rates of 14.2% each year.


Discover healthy companies